Tubeless Insulin Pump Market: By Type (Animas Insulin Pumps, Medtronic Insulin Pumps), By End-use (Homecare, Hospitals, Clinics), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Tubeless Insulin Pump Market size was valued at USD 1,376.3 million in 2022 and is poised to grow at a significant CAGR of 24.9% from 2023-2029. Tubeless insulin pumps, also known as insulin patch pumps, are small, inconspicuous, and lightweight. These items are unobtrusive, low-cost, easily cling to the human body, and simple to use. According to the NCBI, individuals with type 1 diabetes prefer tubeless insulin pumps. These pumps now employ Nitinol wire, a spring, a step motor, a piezoelectric crystal, a manual pumping chamber, and a bladder for insulin administration. These tubeless insulin pumps come in a variety of sizes and technology. These items may be worn and handled successfully beneath garments. With an increase in diabetes incidence, particularly among older patients, the tubeless insulin pump market is expected to rise significantly in the future years. Based on end-use, the home care segment accounted for a significant market share of more than 76% in 2021 and is expected to drive the market growth during the forecast period owing to the rising use of these technologies in home care settings. Recent technological advances and the inclusion of innovative modalities have created a novel, user-friendly gadgets. The availability of these simple-to-use devices is expected to accelerate the growth of the tubeless insulin pump industry. These pumps typically include a tiny pod or patch containing insulin units in the reservoir and a personal diabetes therapeutics manager who assists in managing and adjusting insulin administration. One of the major reasons impacting the tubeless insulin pump market share is the significant growth in the number of diabetic patients. With an increasing patient population, the market is predicted to increase dramatically because of the growing desire for tubeless insulin pumps due to its dependability and reduced need for numerous injections.

Tubeless Insulin Pump Market Key Developments:

  • In August 2021, Insulet Corporation has received FDA permission to use Eli Lilly's Lyumjev injection in conjunction with Insulet's Omnipod Insulin Management System and Omnipod DASH Insulin Management System. This FDA clearance enabled the firm to provide more clinical options for diabetic patients to maintain their glucose levels and reduce post-meal increases.

Tubeless Insulin Pump Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

24.9%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Tubeless Insulin Pump Market Dynamics

The diabetes treatment sector has made significant progress. Over the last several years, a slew of insulin pump technologies with enhanced hyperglycemia and hypoglycemia control and patient comfort has been released. In general, the evolution of demand for these insulin pumps, particularly tubeless pumps, has been influenced by a shifting regulatory landscape and apparent continual scientific improvements. Advances in continuous insulin delivery systems, particularly automation, have opened enormous opportunities. The tubeless insulin pump industry has experienced new growth trajectories due to medical device manufacturers' constant attempts to provide patients with more options. Aside from that, the usage of tubeless insulin pumps has improved quality of life metrics compared to multiple-dose insulin injections. Fast evolving demand for smart insulin pumps in developed countries has opened new avenues in other regions.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Tubeless Insulin Pump Market Segmentation

By Type
  • Animas Insulin Pumps
  • Medtronic Insulin Pumps
By End-use
  • Homecare
  • Hospitals
  • Clinics
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The tubeless insulin pump market size was valued at USD 1,376.3 million in 2022

The tubeless insulin pump market key players are: Insulet Corporation Johnson & Johnson Medtrum Technologies Cellnova Roche Holdings Spring Health Solutions Debiotech CeQur Valeritas Holding Abbott Diabetes Care Medtronic Plc. Tandem Diabetes Care Insulet Corporation Animas Corporation Others

The tubeless insulin pump market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1. Executive Summary
2. Global Tubeless Insulin Pump Market Introduction 
2.1.Global Tubeless Insulin Pump Market  - Taxonomy
2.2.Global Tubeless Insulin Pump Market  - Definitions
2.2.1.Product Type 
2.2.2.Disease Type
2.2.3.End Users
2.2.4.Region
3. Global Tubeless Insulin Pump Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Tubeless Insulin Pump Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Tubeless Insulin Pump Market  By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Corneal Pachymeters
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Optical Coherence Tomography (OCT) Imaging Systems
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Retinal Tomography and Angiography Systems
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Spectral Domain Optical Coherence Tomography (OCT) Systems
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Tonometers
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Visual Field Testing Equipment
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Others
5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6. Global Tubeless Insulin Pump Market  By Disease Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Closed Angle Glaucoma
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Open Angle Glaucoma
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Pigmentary Glaucoma
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Low Tension Glaucoma
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Tubeless Insulin Pump Market  By End Users, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Ophthalmology
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Diagnostic Centers
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Research Institutes
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Tubeless Insulin Pump Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Tubeless Insulin Pump Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Product Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Corneal Pachymeters
9.1.2.Optical Coherence Tomography (OCT) Imaging Systems
9.1.3.Retinal Tomography and Angiography Systems
9.1.4.Spectral Domain Optical Coherence Tomography (OCT) Systems
9.1.5.Tonometers
9.1.6.Visual Field Testing Equipment
9.1.7.Others
9.2.  Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Closed Angle Glaucoma
9.2.2.Open Angle Glaucoma
9.2.3.Pigmentary Glaucoma
9.2.4.Low Tension Glaucoma
9.2.5.Others
9.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Ophthalmology
9.3.3.Diagnostic Centers
9.3.4.Research Institutes
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Tubeless Insulin Pump Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Corneal Pachymeters
10.1.2.Optical Coherence Tomography (OCT) Imaging Systems
10.1.3.Retinal Tomography and Angiography Systems
10.1.4.Spectral Domain Optical Coherence Tomography (OCT) Systems
10.1.5.Tonometers
10.1.6.Visual Field Testing Equipment
10.1.7.Others
10.2.  Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Closed Angle Glaucoma
10.2.2.Open Angle Glaucoma
10.2.3.Pigmentary Glaucoma
10.2.4.Low Tension Glaucoma
10.2.5.Others
10.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Ophthalmology
10.3.3.Diagnostic Centers
10.3.4.Research Institutes
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Tubeless Insulin Pump Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Corneal Pachymeters
11.1.2.Optical Coherence Tomography (OCT) Imaging Systems
11.1.3.Retinal Tomography and Angiography Systems
11.1.4.Spectral Domain Optical Coherence Tomography (OCT) Systems
11.1.5.Tonometers
11.1.6.Visual Field Testing Equipment
11.1.7.Others
11.2.  Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Closed Angle Glaucoma
11.2.2.Open Angle Glaucoma
11.2.3.Pigmentary Glaucoma
11.2.4.Low Tension Glaucoma
11.2.5.Others
11.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Ophthalmology
11.3.3.Diagnostic Centers
11.3.4.Research Institutes
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Tubeless Insulin Pump Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Corneal Pachymeters
12.1.2.Optical Coherence Tomography (OCT) Imaging Systems
12.1.3.Retinal Tomography and Angiography Systems
12.1.4.Spectral Domain Optical Coherence Tomography (OCT) Systems
12.1.5.Tonometers
12.1.6.Visual Field Testing Equipment
12.1.7.Others
12.2.  Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Closed Angle Glaucoma
12.2.2.Open Angle Glaucoma
12.2.3.Pigmentary Glaucoma
12.2.4.Low Tension Glaucoma
12.2.5.Others
12.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Ophthalmology
12.3.3.Diagnostic Centers
12.3.4.Research Institutes
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Tubeless Insulin Pump Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Corneal Pachymeters
13.1.2.Optical Coherence Tomography (OCT) Imaging Systems
13.1.3.Retinal Tomography and Angiography Systems
13.1.4.Spectral Domain Optical Coherence Tomography (OCT) Systems
13.1.5.Tonometers
13.1.6.Visual Field Testing Equipment
13.1.7.Others
13.2.  Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Closed Angle Glaucoma
13.2.2.Open Angle Glaucoma
13.2.3.Pigmentary Glaucoma
13.2.4.Low Tension Glaucoma
13.2.5.Others
13.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Ophthalmology
13.3.3.Diagnostic Centers
13.3.4.Research Institutes
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Insulet Corporation
14.2.2.Johnson & Johnson
14.2.3.Medtrum Technologies
14.2.4.Cellnova
14.2.5.Roche Holdings
14.2.6.Spring Health Solutions
14.2.7.Debiotech
14.2.8.CeQur
14.2.9.Valeritas Holding
14.2.10.Abbott Diabetes Care
14.2.11.Medtronic Plc.
14.2.12.Tandem Diabetes Care
14.2.13.Insulet Corporation
14.2.14.Animas Corporation
14.2.15.Others
15. Research Methodology 
16. Appendix and Abbreviations 
  • Insulet Corporation
  • Johnson & Johnson
  • Medtrum Technologies
  • Cellnova
  • Roche Holdings
  • Spring Health Solutions
  • Debiotech
  • CeQur
  • Valeritas Holding
  • Abbott Diabetes Care
  • Medtronic Plc.
  • Tandem Diabetes Care
  • Insulet Corporation
  • Animas Corporation
  • Others

Adjacent Markets